On March 15, 2023, the Honorable Karen Marston of the United States District Court for the Eastern District of Pennsylvania granted final approval of a $39.8 million settlement to resolve antitrust claims against Johnson & Johnson alleging that the company launched its “Biosimilar Readiness Plan” to block health care providers from purchasing competitor products of its infliximab biosimilar, Remicade.
On February 27, 2023, the Honorable Rodney Smith of the United States District Court for the Southern District of Florida granted final approval of a $33 million settlement to resolve anti-trust claims brought against Norwegian salmon farming companies Mowi ASA, Grieg Seafood ASA, Ocean Quality AS, Salmar ASA, Cermaq, and Lerøy Seafood USA Inc. The settlement received Preliminary Approval on October 6, 2022.
On January 5, 2023, the Federal Trade Commission unveiled a Notice of Proposed Rulemaking that would ban virtually all employment-related non-compete agreements on the ground that such agreements are an “unfair method of competition,” thereby violating Section 5 of the FTC Act.
The lawsuit alleges that Defendants engaged in monopolistic behavior to delay the production of a generic form of AstraZeneca’s antidepressant drug Seroquel XR (quetiapine fumarate extended-release tablets) (“Seroquel XR”), thereby forcing both pharmaceutical wholesalers (“Direct Purchasers”) and persons and entities (“End-Payors,” and, with the Direct Purchasers, “Plaintiffs”)) to buy the more expensive Seroquel XR, costing purchasers millions of dollars.
On October 6, 2022, a proposed class of indirect salmon buyers obtained a class-wide settlement of $33 million to resolve antitrust claims against Norwegian salmon producers, alleging that they inflated farm-raised salmon prices in the United States. In the preliminary approval motion, counsel for the Settlement Class indicated that the settlement is “an excellent result for the class” since it would avoid lengthy litigation and the uncertainties of prosecution against foreign defendants.
Telephone: 866-540-5505 • Fax: 866-300-7367 | Se habla Español
19712 MacArthur Boulevard, Suite 222
Irvine, CA 92612
Map and Directions
1230 Columbia Street, Suite 1140
San Diego, CA 92101
Map and Directions
456 Montgomery Street, Suite 1900
San Francisco, CA 94104
Map and Directions
65 Main Street
Chester, CT 06412
Map and Directions
1625 N. Commerce Pkwy, Suite 320
Fort Lauderdale, FL 33326
Map and Directions
2 Hudson Place, Suite 100
Hoboken, NJ 07030
Map and Directions
225 Broadway, Suite 1830
New York, NY 10007
Map and Directions
1845 Walnut Street, Suite 806
Philadelphia, PA 19103
Map and Directions